[1]陈可靖.甲状腺癌131I显像假阳性的分析及鉴别诊断[J].国际放射医学核医学杂志,2000,24(1):11-14.
　CHEN Ke-jing.The analysis and diferentiate diagnosis of false positive 131I imaging in metastatic thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(1):11-14.
点击复制

甲状腺癌131I显像假阳性的分析及鉴别诊断(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
24
期数:
2000年第1期
页码:
11-14
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
The analysis and diferentiate diagnosis of false positive 131I imaging in metastatic thyroid carcinoma
作者:
陈可靖
200032 上海, 上海医科大学附属中山医院核医学科
Author(s):
CHEN Ke-jing
Department of Nuclear medicine, Zhongshan Hospital Shanghai Medical University, Shanghai 200032, China
关键词:
分化型甲状腺癌; 131I显像; 假阳性; 人甲状腺球蛋白
Keywords:
differentiated thyroid carcinoma; 131I imaging; false positive; thyroglobulin
分类号:
R736.1
摘要:
131I显像是诊断分化型甲状腺转移癌的特异方法,有关报道显示该方法,有关报道显示该方法诊断甲状腺转移癌的特异性为96%,灵敏度80%。但近年来也有不少报道指出假阳性结果的存在,如额窦粘液囊肿、胸腺、肺癌、乳房、食道良性狭窄、结肠移植物、胃上移、肾囊肿等均可见有131I的蓄积,尽管其发生率不高,但常干扰诊断,导致病员接受不必要的对照。因此,对假阳结果的出现部位,产生原因及可能的鉴别方法应该有所了解。为了得到正确诊断,可合并应用其他影像诊断方法,或辅以201Tl显像,或辅以测定血中人甲状腺球蛋白(h-TG),以利于用药。
Abstract:
131I imaging is a specific method for demonstrating metastatic differentiated thyroid carcinoma. It was reported that its specificity and sensitivity were 96% and 80% respectively, but false positive results also existed: many tissues besides thyroid can accumulate 131I such as frontal sinus mucocele, thymus, lung carcinoma, breast, esophagus benign stricture, colon graft, gastric pull-up, renal cyst etc. Although its incidence is low,it often misleads the diagnosis and brings unnecessary radiation to the patients. So it is necessary to make sure the location, cause and possible differentiate way of false positive results. In order to get correct diagnosis results, it is suggested to use other imaging modality or 201Tl imaging together and detect serum h-Tg at the same time.

参考文献/References:

[1] Matheja P, Lerch H, Schmid KW, et al. Frontal sinus mucoccele mimicking a metastasis of papillary thyroid carcinoma[J]. J Nucl Med, 1997, 38:1022~1024.
[2] Vermiglio F, Baudin E, Travagli JP, et al. Iodine Con-centration by thymus in thyroid carcinoma[J]. J Nucl Med, 1996, 37:1803~1831.
[3] Bakheet SM, Powe J, Hammami MM. Radioiodine uptake in the chest[J]. J Nucl Med, 1997, 38:984~986.
[4] Wen C, Luanow E, Oates E et al. Post-therapy Iodi-ne-131 localization in unsuspected large renal cyst:possible mechanisms[J]. J Nucl Med, 1998, 39:2158~2161.
[5] Chung JK, Lee YJ, Jeong JM, et al. Clinical significance of hepatic visualization on Iodine-131 whole-body scan in patients with thyroid carcinoma[J]. J Nucl Med, 1997, 38:1191~1195.
[6] Bakheet S, Hammami MM. False-positive thyroid can-cer metastas on whole-body radioiodine scanning due to retined radioactivity in the esophagus[J]. Eur J Nucl Med, 1993, 20:415~419.
[7] Hammami MM, Bakheet SM. Radioiodine breast uptake in nonbreastfeeding women clinical and scintigraphic characteristics[J]. J Nucl Med, 1996, 37:26~31.
[8] Bakheet SM, Hammami MM. Patterns of radioiodine uptake by the lactating breast[J]. Eur J Nucl Med, 1994, 21:604~608.
[9] Grunwald F, Menzel C, Fimmers R, et al. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer[J]. J Nucl Med, 1996, 37:1962~1964.
[10] Dadparvar S, Krishna L, Luther W, et al. The role of Iodine-131 and Thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma[J]. Cancer, 1993, 71:3767~3773.

相似文献/References:

[1]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
　Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[2]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
　Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[3]叶智轶,王辉,吴靖川.维甲酸在诱导再分化治疗分化型甲状腺癌中的价值[J].国际放射医学核医学杂志,2007,31(4):221.
　YE Zhi-yi,WANG Hui,WU Jing-chuan.The value of retinoic acid-induced redifferentiation in the treatment of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):221.
[4]马寄晓,叶大铸.奥曲肽及其类似物用于肿瘤治疗的进展[J].国际放射医学核医学杂志,2005,29(2):79.
　MA Ji-xiao,YE Da-zhu.Advances in tumor treatment with labeled somatostatin analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):79.
[5]罗全勇,朱瑞森.分化型甲状腺癌患者血清Tg和TgAb检测与结果分析应注意的问题[J].国际放射医学核医学杂志,2004,28(5):197.
　LUO Quan-yong,ZHU Rui-sen.Critical problems in the measurement and clinical evaluation of serum thyroglobulin and thyroglobulin antibody in differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(1):197.
[6]丁昊,叶斌,雷勇.增强DTC病灶摄取131I功能的措施[J].国际放射医学核医学杂志,2001,25(4):145.
　DING Hao,YIE Bin,LEI Yong.The augmentation of 131I uptake of DTC[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):145.
[7]康玉国.分化型甲状腺癌18F-FDG PET显像的临床应用[J].国际放射医学核医学杂志,2000,24(6):264.
　KANG Yuguo.Application of 18F-FDG PET scan in patients with differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(1):264.
[8]张渊琪,赵德善.分化型甲状腺癌的治疗进展[J].国际放射医学核医学杂志,2017,41(2):126.[doi:10.3760/cma.j.issn.1673-4114.2017.02.009]
　Zhang Yuanqi,Zhao Deshan.Advances in the treatment of differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):126.[doi:10.3760/cma.j.issn.1673-4114.2017.02.009]
[9]管昌田.分化型甲状腺癌术后复发和转移的早期诊断及处理[J].国际放射医学核医学杂志,1995,19(4):156.
[10]钞卫光,张晶,陆克义.分化型甲状腺癌腹盆部131I显像假阳性分析[J].国际放射医学核医学杂志,2017,41(5):370.[doi:10.3760/cma.j.issn.1673-4114.2017.05.012]
　Chao Weiguang,Zhang Jing,Lu Keyi.Analysis of differentiated thyroid cancer false-positive uptake in abdominal cavity and pelvic cavity on radioiodine whole-body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):370.[doi:10.3760/cma.j.issn.1673-4114.2017.05.012]

备注/Memo

备注/Memo:
收稿日期:1999-12-18。
作者简介:陈可靖(1936-),女,山东省济南人,上海医科大学附属中山医院核医学科教授,博士生导师,主要从事放射性核素治疗的研究。
更新日期/Last Update: 1900-01-01